-+ 0.00%
-+ 0.00%
-+ 0.00%

Keefe, Bruyette & Woods Maintains Outperform on Crescent Capital BDC, Lowers Price Target to $13

Benzinga·06/16/2026 15:36:02
Listen to the news
Keefe, Bruyette & Woods analyst Paul Johnson maintains Crescent Capital BDC (NASDAQ:CCAP) with a Outperform and lowers the price target from $15 to $13.